Synthesis and evaluation of fluorine-18 21-fluoroprednisone as a potential ligand for neuro-PET studies Journal Article


Authors: Feliu, A. L.; Rottenberg, D. A.
Article Title: Synthesis and evaluation of fluorine-18 21-fluoroprednisone as a potential ligand for neuro-PET studies
Abstract: No-carrier-added fluorine-18-labeled fluoroprednisone ([18F]21-fluoroprednisone) was synthesized by tosylate displacement in 2%-8% radiochemical yield in 80 min end of cyclotron bombardment (EOB), and its metabolism and distribution were investigated. After intravenous administration to rats, [18F]21-fluoroprednisone was rapidly cleared from the blood and biotransformed into [18F]20-dihydro-21-fluoroprednisone. The suitability of [18F]21-fluorocorticoids for receptor imaging in humans with positron emitting tomography will depend on the synthesis of compounds with high binding affinity and low rate of carbonyl reduction at C-20.
Keywords: unclassified drug; human cell; prednisone; methodology; animal; metabolism; animal experiment; drug synthesis; liver; drug distribution; isotope labeling; tissue distribution; rat; drug clearance; rats; drug monitoring; drug metabolism; drug blood level; high performance liquid chromatography; radioisotope; radioisotopes; synthesis; intravenous drug administration; normal human; pharmacokinetics; tomography, emission-computed; receptors, glucocorticoid; nervous system; drug solubility; drug identification; fluorine; body distribution; human; priority journal; support, u.s. gov't, p.h.s.; blood and hemopoietic system; drug analysis; 21 fluoro 20 dihydroprednisone f 18; 21 fluoroprednisone f 18
Journal Title: Journal of Nuclear Medicine
Volume: 28
Issue: 6
ISSN: 0161-5505
Publisher: Society of Nuclear Medicine  
Date Published: 1987-06-01
Start Page: 998
End Page: 1005
Language: English
PUBMED: 3495649
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 5 February 2021 -- Source: Scopus
Citation Impact
MSK Authors
  1. Anthony Feliu
    8 Feliu